Go Pro
→ They didn't warn anyone in 1971. This time someone is warning you. (From Reagan Gold Group) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$108.85
0.0%		$95.13
$50.87
▼
$110.25
$88.25M1.211,080 shs10,769 shs
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$40.03
-0.2%		$37.67
$26.54
▼
$42.87
$942.71M0.45242,932 shs83,813 shs
LFSC
F/m Emerald Life Sciences Innovation ETF
$47.02
-0.8%		$43.89
$24.75
▼
$47.68
$128.84M0.934,747 shs3,310 shs
MEDX
Horizon Kinetics Medical ETF
$36.03
$35.27
$27.15
▼
$37.79
$17.66M0.462,084 shs429 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
+2.14%+13.30%+5.77%+27.90%+114.29%
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
+1.21%+3.91%+4.65%+16.84%+52.10%
LFSC
F/m Emerald Life Sciences Innovation ETF
+0.79%+3.95%+2.44%+23.62%+87.65%
MEDX
Horizon Kinetics Medical ETF
+1.44%+4.04%+0.95%+9.21%+32.25%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$108.85
0.0%		$95.13
$50.87
▼
$110.25
$88.25M1.211,080 shs10,769 shs
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$40.03
-0.2%		$37.67
$26.54
▼
$42.87
$942.71M0.45242,932 shs83,813 shs
LFSC
F/m Emerald Life Sciences Innovation ETF
$47.02
-0.8%		$43.89
$24.75
▼
$47.68
$128.84M0.934,747 shs3,310 shs
MEDX
Horizon Kinetics Medical ETF
$36.03
$35.27
$27.15
▼
$37.79
$17.66M0.462,084 shs429 shs
10 Best Stocks to Own - Summer 2026 Cover
10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
+2.14%+13.30%+5.77%+27.90%+114.29%
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
+1.21%+3.91%+4.65%+16.84%+52.10%
LFSC
F/m Emerald Life Sciences Innovation ETF
+0.79%+3.95%+2.44%+23.62%+87.65%
MEDX
Horizon Kinetics Medical ETF
+1.44%+4.04%+0.95%+9.21%+32.25%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
2.70
Moderate Buy$109.130.25% Upside
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
2.67
Moderate Buy$39.99-0.10% Downside
LFSC
F/m Emerald Life Sciences Innovation ETF
2.79
Moderate Buy$47.02N/A
MEDX
Horizon Kinetics Medical ETF
2.69
Moderate Buy$36.03N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/AN/AN/AN/AN/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/AN/AN/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/AN/A20.68N/AN/AN/AN/AN/AN/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/AN/A14.51N/AN/AN/AN/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/AN/A19.02N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
$0.320.29%N/AN/AN/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
$0.421.05%N/AN/AN/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/AN/AN/AN/AN/A
MEDX
Horizon Kinetics Medical ETF
$0.501.39%N/AN/AN/A

Latest MEDX, LFSC, FTXH, and BIB Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/24/2026
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
Quarterly$0.09200.99%6/25/20266/25/20266/30/2026
(Data available from 1/1/2013 forward)

Institutional Ownership

CompanyInstitutional Ownership
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/A
MEDX
Horizon Kinetics Medical ETF
62.18%

Insider Ownership

CompanyInsider Ownership
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/A
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
N/A
LFSC
F/m Emerald Life Sciences Innovation ETF
N/A
MEDX
Horizon Kinetics Medical ETF
4.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
ProShares Ultra Nasdaq Biotechnology stock logo
BIB
ProShares Ultra Nasdaq Biotechnology
N/A810,000N/AOptionable
First Trust Nasdaq Pharmaceuticals ETF stock logo
FTXH
First Trust Nasdaq Pharmaceuticals ETF
147,00023.55 millionN/AOptionable
LFSC
F/m Emerald Life Sciences Innovation ETF
N/A2.74 millionN/AN/A
MEDX
Horizon Kinetics Medical ETF
N/A490,000N/ANot Optionable

Recent News About These Companies

Medical ETF (MEDX) Touches New 52-Week High
February 24, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2874077/medical-etf-medx-touches-new-52-week-high?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2874077
Horizon Kinetics Holding Corporation Reports First Quarter Results
May 14, 2025  |  accessnewswire.comA
Horizon Kinetics Holding Corporation Reports Fourth Quarter and Annual Results
March 26, 2025  |  accessnewswire.comA
ETFs to Buy as Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 1, 2024  |  zacks.comhttps://www.zacks.com/stock/news/2266174/etfs-to-buy-as-eli-lilly-beats-q1-earnings-lifts-outlook?cid=cs-stocknewsapi-ft-etf_news_and_commentary-2266174
Horizon Kinetics ISE Wealth (RCH)
May 13, 2023  |  uk.investing.comhttps://uk.investing.com/indices/horizon-kinetics-ise-wealth
HORIZON Fushi ChinaA 50 ETF (512150)
May 11, 2023  |  investing.comhttps://www.investing.com/etfs/horizon-fushi-chinaa-50
Horizon Kinetics Launches the Horizon Kinetics SPAC Active ETF (SPAQ) and the Horizon Kinetics Medical ETF (MEDX)
April 19, 2023  |  finance.yahoo.comhttps://finance.yahoo.com/news/horizon-kinetics-launches-horizon-kinetics-213500961.html?.tsrc=rss

New MarketBeat Followers Over Time

Media Sentiment Over Time

ProShares Ultra Nasdaq Biotechnology stock logo

ProShares Ultra Nasdaq Biotechnology NASDAQ:BIB

$108.85 -0.01 (-0.01%)
As of 02:33 PM Eastern
This is a fair market value price provided by Massive. Learn more.

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day's returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period. The Fund does not seek to achieve its stated investment objective over a period of time greater than one day. The Fund invests in derivatives that have similar daily performance characteristics as the inverse of the daily return of the Index. The Fund invests in financial instruments whose value is derived from the value of an underlying asset, interest rate or index. ProShare Advisors LLC is the investment advisor of the Fund.

First Trust Nasdaq Pharmaceuticals ETF stock logo

First Trust Nasdaq Pharmaceuticals ETF NASDAQ:FTXH

$40.03 -0.07 (-0.17%)
As of 02:12 PM Eastern

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.

F/m Emerald Life Sciences Innovation ETF NASDAQ:LFSC

$47.02 -0.40 (-0.84%)
As of 11:49 AM Eastern

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.

Horizon Kinetics Medical ETF NASDAQ:MEDX

$36.03 0.00 (0.00%)
As of 08/10/2026 02:51 PM Eastern

The Horizon Kinetics Medical ETF (MEDX) is an exchange-traded fund that mostly invests in health care equity. The fund actively invests in global companies within the broad health care sector. Stock selection and weighting emphasizes those invested in cancer research and pharmaceutical developments. MEDX was launched on Jan 27, 2023 and is managed by Horizon Kinetics.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas